Trials / Completed
CompletedNCT03936569
A Clinical Study to Assess the Plaque and Gingivitis Effects of a Stannous Fluoride Dentifrice
A 3-Month Clinical Study to Assess the Plaque and Gingivitis Effects of a Stannous Fluoride Dentifrice
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this clinical study is to assess the effects of a 0.454% stannous fluoride dentifrice on gingivitis and plaque after 3 months when compared to a negative control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Marketed Toothpaste | Marketed stannous fluoride (0.454%) toothpaste |
| DRUG | Marketed Cavity Protection Toothpaste | Marketed sodium monofluorophosphate (0.76 %) toothpaste |
Timeline
- Start date
- 2018-10-29
- Primary completion
- 2019-01-25
- Completion
- 2019-01-25
- First posted
- 2019-05-03
- Last updated
- 2023-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03936569. Inclusion in this directory is not an endorsement.